Braveheart Bio to Participate in Stifel Cardiometabolic Forum
Braveheart Bio, Inc. (NASDAQ: BRVE) announced it will participate in the Stifel Cardiometabolic Forum, according to a Globe Newswire release.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.